Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CM336
/
Keymed Biosciences
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
||
||||||||
CM336
/
Keymed Biosciences
New P1/2 trial:
A Study of CM336 in Patients With Relapsed or Refractory Multiple Myeloma
(clinicaltrials.gov) - Mar 28, 2022
P1/2
, N=48, Not yet recruiting,
Sponsor: Keymed Biosciences Co.Ltd